Viemed Healthcare, Inc. filed a Current Report on Form 8-K with the SEC on November 4, 2026, disclosing its financial results for the three and nine months ended September 30, 2026, along with a Financial Supplement and an Investor Deck Presentation.

Key Highlights

  • Reporting periods covered: Financial results were announced for both the three months and the nine months ended September 30, 2026.
  • Exhibits filed: The filing attaches a press release (Exhibit 99.1), a Financial Supplement (Exhibit 99.2), and an Investor Deck Presentation (Exhibit 99.3), all dated November 4, 2026.
  • Investor Deck use: According to the filing, the company expects to use the Investor Deck Presentation in presentations to investors, analysts, and others, possibly with modifications.
  • Not "filed" for Section 18 purposes: The filing states that the results information and exhibits under Items 2.02 and 7.01 "shall not be deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934."
  • Signed by CFO: The report was signed by Trae Fitzgerald, Chief Financial Officer of Viemed Healthcare, Inc.

Viemed Healthcare Announces Third-Quarter 2026 Operating Results via Form 8-K

Viemed Healthcare, Inc. (NASDAQ:VMD), a home health equipment and services company incorporated in British Columbia, Canada, and headquartered at 625 E. Kaliste Saloom Rd., Lafayette, Louisiana, submitted this Current Report under Item 2.02 (Results of Operations and Financial Condition) to announce earnings for the quarter and nine-month period ending September 30, 2026. The press release and Financial Supplement, both incorporated by reference, serve as the primary disclosure vehicles for the operational and financial data underlying the announcement.

Under Item 7.01, the company disclosed a Regulation FD submission consisting of an Investor Deck Presentation. According to the filing, that presentation contains "summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission filings and other public announcements." The company stated it "undertakes no duty or obligation to publicly update or revise the information contained in the Investor Deck Presentation, except as required by law," though it noted it may do so when management believes it is warranted, through regulatory filings, press releases, or other public disclosures.

The filing notes that the information presented under Item 7.01 and Exhibit 99.3 "shall not be deemed to be 'filed' for purposes of Section 18 of the Exchange Act," unless the company specifically states otherwise. This distinction, standard for Regulation FD disclosures, limits the liabilities that would otherwise attach to formally filed documents under the Exchange Act.

What Was Disclosed

Viemed Healthcare filed an 8-K on November 4, 2026, covering results for the three and nine months ended September 30, 2026. Three exhibits were attached: a press release, a Financial Supplement, and an Investor Deck Presentation, all dated November 4, 2026.